11 reports

  • Market participants

HOFFMANN-LA ROCHE: KEY OFFERINGS DESCRIPTION IT IS A MOUSE MONOCLONAL ANTIBODY INDICATED AFTER CLINICAL DIFFERENTIAL DIAGNOSIS AS AN AID IN THE IDENTIFICATION OF PROSTATIC ADENOCARCINOMA WITHIN the context of an antibody panel, the patient' s clinical history, and othe

  • Biopsy
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • MDxHealth SA
  • OPKO Health, Inc.

Excisional Biopsy ##.

  • Biopsy
  • United States
  • B. Braun Melsungen AG
  • Becton Property Group
  • Boston Scientific Corporation

VALEANT IS HEADQUARTERED IN LAVAL, QUEBEC, CANADA. ##. ## VALEANT PHARMACEUTICALS INTERNATIONAL INC ##. ##. ## COMPANY OVERVIEW APOLLO ENDOSURGERY INC (APOLLO ENDO), FORMERLY LPATH INC, DISCOVERS AND DEVELOPS MONOCLONAL ANTIBODIES THAT TARGET BIOACTIVE LIPIDS.

  • Biopsy
  • Latin America
  • Mexico
  • North America
  • Forecast

VALEANT IS HEADQUARTERED IN LAVAL, QUEBEC, CANADA. ##. ## VALEANT PHARMACEUTICALS INTERNATIONAL INC ##. ##. ## COMPANY OVERVIEW APOLLO ENDOSURGERY INC (APOLLO ENDO), FORMERLY LPATH INC, DISCOVERS AND DEVELOPS MONOCLONAL ANTIBODIES THAT TARGET BIOACTIVE LIPIDS.

  • Biopsy
  • Australasia
  • Australia
  • Oceania
  • Forecast

THE TECHNOLOGY USES TWO ANTIBODIES, ONE THAT CAPTURES NUCLEOSOMES AND THE OTHER, LABELLED ANTIBODY, THAT DETECTS A PARTICULAR EPIGENETIC SIGNAL.

  • Biopsy
  • North America
  • United States
  • Market Size
  • Biocept, Inc.

Working unrelentingly in the last ## years to overcome these obstacles, Abnova has developed a proprietary panel of monoclonal antibodies targeting fRNBCs, a combined positive and negative cell enrichment technology, and a NGS-based SNP analysis and sequencing.

  • Biopsy
  • Clinical Trial
  • Medical Device
  • United States
  • Verisante Technology, Inc.

Biopharmaceuticals, such as monoclonal antibodies are the world' s fastest-growing class of medicine.

  • Biopsy
  • Diagnostic Imaging
  • Magnetic Resonance Imaging
  • United States
  • Company

Biopharmaceuticals, such as monoclonal antibodies are the world' s fastest-growing class of medicine.

  • Biopsy
  • Diagnostic Imaging
  • Ultrasound
  • United States
  • Company

Figure ##-##: B.

  • Biopsy
  • United States
  • World
  • Forecast
  • M&A

THE PHASE ## PROGRAM EVALUATING dupilumab, an anti-IL##Rα monoclonal antibody, in nasal polyposis was initiated.

  • Biopsy
  • Body Contouring Device
  • France
  • Western Europe
  • Forecast

INVESTMENT IN RESEARCH AND DEVELOPMENT INCREASED $## MILLION, OR ##%, TO $## MILLION IN THE FIRST QUARTER OF 2016, PRIMARILY DUE TO THE DEVELOPMENT PROGRAMS RELATED TO THE COMPANY' S DERMATOLOGY PRODUCT PORTFOLIO, INCLUDING IDP- ##, AS WELL AS BRODALUMAB, AN IL-## RECEPTOR MONOCLONAL

  • Biopsy
  • Canada
  • North America
  • Forecast
  • Olympus Corporation